Aaron Clausen, Ph.D. - Related publications

Neuroscience University of Southern California, Los Angeles, CA, United States 
glutamate receptors, LTP, neurodegeneration, calpain
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
23 most relevant papers in past 60 days:
Year Citation  Score
2021 Talebi M, İlgün S, Ebrahimi V, Talebi M, Farkhondeh T, Ebrahimi H, Samarghandian S. Zingiber officinale ameliorates Alzheimer's disease and Cognitive Impairments: Lessons from preclinical studies. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 133: 111088. PMID 33378982 DOI: 10.1016/j.biopha.2020.111088   
2021 Stojakovic A, Trushin S, Sheu A, Khalili L, Chang SY, Li X, Christensen T, Salisbury JL, Geroux RE, Gateno B, Flannery PJ, Dehankar M, Funk CC, Wilkins J, Stepanova A, et al. Partial inhibition of mitochondrial complex I ameliorates Alzheimer's disease pathology and cognition in APP/PS1 female mice. Communications Biology. 4: 61. PMID 33420340 DOI: 10.1038/s42003-020-01584-y   
2021 Zhang G, Wu J, Huang C, Cheng J, Su Z, Zhu Z, Yang X, Guo B, Wu L, Zhang Z, Zhang G, Chen H, Sun Y, Wang Y. The Tetramethylpyrazine Analogue T-006 Alleviates Cognitive Deficits by Inhibition of Tau Expression and Phosphorylation in Transgenic Mice Modeling Alzheimer's Disease. Journal of Molecular Neuroscience : Mn. PMID 33403592 DOI: 10.1007/s12031-020-01762-x   
2021 Papp KV, Rentz DM, Maruff P, Sun CK, Raman R, Donohue MC, Schembri A, Stark C, Yassa MA, Wessels AM, Yaari R, Holdridge KC, Aisen PS, Sperling RA. The Computerized Cognitive Composite (C3) in an Alzheimer's Disease Secondary Prevention Trial. The Journal of Prevention of Alzheimer's Disease. 8: 59-67. PMID 33336226 DOI: 10.14283/jpad.2020.38   
2021 Zeng L, Zhang D, Liu Q, Zhang J, Mu K, Gao X, Zhang K, Li H, Wang Q, Zheng Y, Mao S. Alpha-asarone Improves Cognitive Function of APP/PS1 Mice and Reducing Aβ P-tau and Neuroinflammation, and Promoting Neuron Survival in the Hippocampus. Neuroscience. PMID 33412244 DOI: 10.1016/j.neuroscience.2020.12.026   
2021 Salisbury D, Plocher T, Yu F. Efficacy of simultaneous aerobic exercise and cognitive training in subjective cognitive decline: study protocol for randomized controlled trial of the Exergames Study. Trials. 22: 14. PMID 33407727 DOI: 10.1186/s13063-020-04950-7   
2021 Shin SJ, Nam Y, Park YH, Kim MJ, Lee E, Jeon SG, Bae BS, Seo J, Shim SL, Kim JS, Han CK, Kim S, Lee YY, Moon M. Therapeutic effects of non-saponin fraction with rich polysaccharide from Korean red ginseng on aging and Alzheimer's disease. Free Radical Biology & Medicine. PMID 33422674 DOI: 10.1016/j.freeradbiomed.2020.12.454   
2021 Lane HY, Tu CH, Lin WC, Lin CH. Brain activity of benzoate, a D-amino acid oxidase inhibitor, in patients with mild cognitive impairment in a randomized, double-blind, placebo controlled clinical trial. The International Journal of Neuropsychopharmacology. PMID 33406269 DOI: 10.1093/ijnp/pyab001   
2021 Li Y, Fang R, Liu Z, Jiang L, Zhang J, Li H, Liu C, Li F. The association between toxic pesticide environmental exposure and Alzheimer's disease: A scientometric and visualization analysis. Chemosphere. 263: 128238. PMID 33297185 DOI: 10.1016/j.chemosphere.2020.128238   
2021 Day GS, Gordon BA, McCullough A, Bucelli RC, Perrin RJ, Benzinger TLS, Ances BM. Flortaucipir (tau) PET in LGI1 antibody encephalitis. Annals of Clinical and Translational Neurology. PMID 33410601 DOI: 10.1002/acn3.51297   
2021 Tomaru U, Ito T, Ohmura Y, Higashikawa K, Miyajima S, Tomatsu R, Higashi T, Ishizu A, Kuge Y, Yoshioka M, Kasahara M. Decreased Proteasomal Function Induces Neuronal Loss and Memory Impairment. The American Journal of Pathology. 191: 144-156. PMID 33339546 DOI: 10.1016/j.ajpath.2020.10.004   
2021 de Erausquin GA, Snyder H, Carrillo M, Hosseini AA, Brugha TS, Seshadri S, . The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33399270 DOI: 10.1002/alz.12255   
2021 Montine TJ, Bukhari SA, White LR. Cognitive Impairment in Older Adults and Therapeutic Strategies. Pharmacological Reviews. 73: 152-162. PMID 33298513 DOI: 10.1124/pharmrev.120.000031   
2021 Chatterjee M, Kwon J, Benedict J, Kamceva M, Kurup P, Lombroso PJ. STEP inhibition prevents Aβ-mediated damage in dendritic complexity and spine density in Alzheimer's disease. Experimental Brain Research. PMID 33420799 DOI: 10.1007/s00221-020-06028-x   
2021 Park JE, Lim DS, Cho YH, Choi KY, Lee JJ, Kim BC, Lee KH, Lee JS. Plasma contact factors as novel biomarkers for diagnosing Alzheimer's disease. Biomarker Research. 9: 5. PMID 33422144 DOI: 10.1186/s40364-020-00258-5   
2021 Cao S, Fisher DW, Rodriguez G, Yu T, Dong H. Comparisons of neuroinflammation, microglial activation, and degeneration of the locus coeruleus-norepinephrine system in APP/PS1 and aging mice. Journal of Neuroinflammation. 18: 10. PMID 33407625 DOI: 10.1186/s12974-020-02054-2   
2021 Rao SS, Lago L, Volitakis I, Shukla JJ, McColl G, Finkelstein DI, Adlard PA. Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 33410108 DOI: 10.1007/s13311-020-00972-w   
2021 Liu X, Dounavi ME, Ritchie K, Wells K, Ritchie CW, Su L, Muniz-Terrera G, O'Brien JT. Higher midlife CAIDE score is associated with increased brain atrophy in a cohort of cognitively healthy middle-aged individuals. Journal of Neurology. PMID 33423129 DOI: 10.1007/s00415-020-10383-8   
2021 Syeda T, Cannon JR. Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target. Journal of Biochemical and Molecular Toxicology. e22694. PMID 33393683 DOI: 10.1002/jbt.22694   
2021 Bao WD, Pang P, Zhou XT, Hu F, Xiong W, Chen K, Wang J, Wang F, Xie D, Hu YZ, Han ZT, Zhang HH, Wang WX, Nelson PT, Chen JG, et al. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease. Cell Death and Differentiation. PMID 33398092 DOI: 10.1038/s41418-020-00685-9   
2021 Ng KP, Pascoal TA, Mathotaarachchi S, Chan YH, Jiang L, Therriault J, Benedet AL, Shin M, Kandiah N, Greenwood CMT, Rosa-Neto P, Gauthier S, . Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease. Translational Neurodegeneration. 10: 1. PMID 33390174 DOI: 10.1186/s40035-020-00225-y   
2021 Pelkmans W, Legdeur N, Ten Kate M, Barkhof F, Yaqub MM, Holstege H, van Berckel BNM, Scheltens P, van der Flier WM, Visser PJ, Tijms BM. Amyloid-β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest-old. Annals of Clinical and Translational Neurology. PMID 33421355 DOI: 10.1002/acn3.51273   
2021 Su Q, Li T, He PF, Lu XC, Yu Q, Gao QC, Wang ZJ, Wu MN, Yang D, Qi JS. Trichostatin A ameliorates Alzheimer's disease-related pathology and cognitive deficits by increasing albumin expression and Aβ clearance in APP/PS1 mice. Alzheimer's Research & Therapy. 13: 7. PMID 33397436 DOI: 10.1186/s13195-020-00746-8